Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07079774

TrueLok Elevate PMCF Study

Sponsor: Orthofix s.r.l.

View on ClinicalTrials.gov

Summary

The TrueLok Elevate Transverse Bone Transport System is a modular external fixation device designed for transverse bone transport. It promotes local vascular and wound healing through controlled corticotomy and gradual distraction. The system is intended for adult patients with bony and/or soft tissuedefects.

Official title: Post-Market Clinical Follow-up Study of the TrueLok Elevate Transverse Bone Transport System for the Treatment of Lower Limb Ulcers as Soft Tissue Defects

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

153

Start Date

2025-11-24

Completion Date

2028-11-24

Last Updated

2026-04-01

Healthy Volunteers

No

Interventions

DEVICE

Transverse Bone Transport System

This is a prospective, international, multicentre, observational post-market clinical follow-up (PMCF) study. Adult subjects will be treated according to the manufacturer's Instructions for Use, with follow-up extending to 12 months post-device removal. Participating sites include centres in the US, Europe, the UK, and South Africa. Subjects will be followed using a phased framework: T0: Index Surgery (baseline data, operative details, ulcer status) T1: End of Distraction (device parameters, adverse events, ulcer status) T2: End of Compression (similar to T1) T3: Device Removal (confirmation of union, ulcer status) Post-removal visits: F3: 3 months F6: 6 months F12: 12 months

Locations (5)

Helios Klinikum Wuppertal GmbH

Wuppertal, Germany

General Regional Hospital F. Miulli of Acquaviva delle Fonti

Acquaviva delle Fonti, Bari, Italy

Stellenbosch University

Cape Town, Western Cape, South Africa

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

Hull University Teaching Hospitals NHS Trust

Hull, Hull, United Kingdom